LHLisa A. Hom

Lisa A. Hom

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lisa A. Hom has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Dual Role of Neonatal Pulse Oximetry Screening and Fetal Echocardiography in Congenital Heart Disease Detection Around the World

    by Anita Krishnan, Carolyn Sommer, Chinenyenwa Mpamaugo, Sonia Voleti Chivukula, Lisa A. Hom, Gerard R. Martin, Mary T. Donofrio

    Congenital heart disease is the most common birth defect worldwide. Perinatal detection, either in utero or prior to hospital discharge is important for planning delivery, ordering adjunct testing, and planning for surgical or medical care. In countries with access to ultrasound screening, prenatal detection is highly accurate though with variable sensitivity and specificity around the world. Pulse oximetry screening, in some cases coupled with murmur auscultation in the nursery can also reach very high degrees of sensitivity for critical congenital heart disease. Use of the modalities per guidelines and recommendations is an important aspect of decreasing infant mortality and morbidity worldwide.

  • Open Access

    Using Mixed-Methods Research to Address Stagnant Operative Mortality Rates in Congenital Heart Surgery

    by Alyssia Venna, Mitchell C. Haverty, Areen Almarkhan, Alix Fetch, Janet Kreutzer, Lisa A. Hom, David L. Wessel, Ashraf S. Harahsheh, Yuliya Domnina, Yves D’UDekem

    IMPORTANCE: Operative mortality rates in the congenital heart disease population have remained stagnant at 2.8% for the last decade, prompting a mixed-methods exploration into what institutional factors might be at play. OBJECTIVES: After experiencing 0% operative mortality for 365 days, we aimed to qualitatively identify institutional factors impacting operative mortality and compare them to perceived reasons for operative mortality. DESIGN: A convergent mixed-methods design was used to compare quantitative and qualitative data. SETTING: This study was performed in a single-center pediatric heart center by a multidisciplinary cardiac research team between January 2020 and June 2024. PARTICIPANTS: A retrospective review of 43 operative mortality records was conducted to determine patient characteristics and reasons for operative mortality. Semi-structured interviews were conducted with staff. ANALYSIS: Quantitative data were analyzed using descriptive statistics to describe patient characteristics and reasons for perceived operative mortality. Qualitative data were analyzed using reflexive thematic analysis to identify themes related to institutional factors influencing operative mortality. Quantitative and qualitative data were compared by matching reasons for each operative mortality to qualitative themes in a joint display. A post hoc descriptive analysis was performed to identify additional perceived reasons for operative mortality following the 0% operative mortality period. RESULTS: Records were assigned up to five reasons for operative mortality: technical failure, communication issues, intractable disease, management strategy, and decision-making. Semi-structured interviews identified institutional factors influencing operative mortality. Reasons for operative mortality were technical failure ( n = 19 [22%]), intractable disease ( n = 19 [22%]), communication ( n = 18 [21%]), management strategy ( n = 15 [18%]), and decision-making ( n = 14 [16%]). Three qualitative themes emerged: 1) Implementing Best Medical Practices, 2) Fostering Healthy Interpersonal Relationships, and 3) Building a Responsive Organizational Structure. Upon comparison, factors encompassed by theme 1 were most comparable when the reason for operative mortality was technical failure, intractable disease, management strategy, or decision-making); theme 2 was most comparable when the reason was communication. Theme 3 was only related to one instance of operative mortality. A post hoc analysis revealed most subsequent deaths following the 0% operative mortality period were attributed to intractable disease. CONCLUSIONS: Efforts to implement best medical practices are critical to improve operative mortality. A considerable effort should also be made to foster healthy relationships among staff. Building a responsive organizational structure may indirectly influence outcomes and should be further explored.

  • Open Access

    Newborn Critical Congenital Heart Disease Screening Using Pulse Oximetry in a Global Context: Progress, Disparities, and the Importance of Early Detection

    by Lisa A. Hom, Gerard R. Martin

    Congenital heart disease (CHD) remains the number one cause of mortality due to congenital defects in children under the age of one


  • Open Access

    Newborn Critical Congenital Heart Disease Screening Using Pulse Oximetry: Value and Unique Challenges in Developing Regions

    by Lisa A. Hom, Gerard R. Martin

    Newborn screening for critical congenital heart disease (CCHD) is recommended for implementation in many developed countries as the standard of care. Efforts to implement this point of care screen in developing regions face unique barriers, and present important opportunities. The First Pan-African Newborn Screening Conference, held in Rabat in June 2019, incorporated a workshop dedicated specifically to identifying and discussing CCHD screening issues in the Middle East Northern Africa (MENA) region. The issues explored may be beneficial as part of the greater discussion of CCHD screening’s growing importance in developing regions around the world. Screening experts presented education and lessons learned from previous CCHD implementations, including a hands-on technical demonstration of CCHD screening. Children’s HeartLink, The Newborn Foundation, and Children’s National Hospital each presented on their experiences working with teams and pilot projects from around the world. Experience in implementation from Children’s Hospital Marrakesh was presented and highlighted some of the unique findings, challenges, and experiences of screening in Morocco. As developing regions investigate the implementation of CCHD screening using pulse oximetry either as part of research studies, pilots, regional studies, or as part of a nationally supported program, data to inform policymakers on the benefits of screening and specific needs for infrastructure development and resources are essential. This special issue contains initial lessons learned on newborn CCHD screening from a select number of developing countries, including Saudi Arabia and Morocco and regions such as Latin America.


  • Open Access

    Pulse Oximetry and Congenital Heart Disease Screening: Results of the First Pilot Study in Morocco

    by Nadia El Idrissi Slitine, Fatiha Bennaoui, Craig A. Sable, Gerard R. Martin, Lisa A. Hom, Amal Fadel, Soufiane Moussaoui, Nadir Inajjarne, Drissi Boumzebra, Youssef Mouaffak, et al.

    Congenital heart disease (CHD) is the most common congenital malformation. Diagnosis of critical congenital heart disease (CCHD), the most severe type of congenital heart disease, in a newborn may be difficult. The addition of CCHD screening, using pulse oximetry, to clinical assessment significantly improves the rate of detection. We conducted a pilot study in Morocco on screening neonates for critical congenital heart disease. This study was conducted in the maternity ward of Mohammed VI University Hospital of Marrakesh, Morocco, and included asymptomatic newborns delivered between March 2019 and January 2020. The screening of CCHD was performed by pulse oximetry measuring the pre- and post-ductal saturation. Screening was performed on 8013/10,451 (76.7%) asymptomatic newborns. According to the algorithm, 7998 cases passed the screening test (99.82%), including one inconclusive test that was repeated an hour later and was normal. Fifteen newborns failed the screening test (0.18%): five CCHD, five false positives, and five CHD but non-critical. One false negative case was diagnosed at 2 months of age. Our results encourage us to strengthen screening for CCHD by adding pulse oximetry to the routine newborn screening panel.


  • Open Access

    Critical Congenital Heart Disease Screening Using Pulse Oximetry: Achieving a National Approach to Screening, Education and Implementation in the United States

    by Lisa A. Wandler, Gerard R. Martin

    A national approach to screening for critical congenital heart disease (CCHD) using pulse oximetry was undertaken in the United States. Following the scientific studies that laid the groundwork for the addition of CCHD screening to the U.S. Recommended Uniform Screening Panel (RUSP) and endorsement by professional societies, advocates including physicians, nurses, parents, medical associations, and newborn screening interest groups were able to successfully pass laws requiring the screen on a state by state basis. Public health involvement and screening requirements vary by state. However, a common algorithm, education, and implementation strategies were shared nationally as well as CCHD toolkits to aid in the implementation in hospitals. Health Resources & Services Administration (HRSA) grants to pilot states encouraged the development of a public health infrastructure around screening, data collection, and quality measures. The formation of a CCHD NewSTEPs technical advisory work group provided a systematic way to tackle challenges and share best practices by hosting monthly meetings and webinars. CCHD screening is now required in 48 states, with over 98% of U.S. births being screened for CCHD using pulse oximetry. A standard protocol has been implemented in most states. While the challenges related to screening special populations and quantifying screening outcomes through the creation of a national data repository remain; universal implementation is nearly complete.


  • The Impact of a Designated Cardiology Team Involving Telemedicine Home Monitoring on the Care of Children with Single-Ventricle Physiology After Norwood Palliation

    by Ashraf S. Harahsheh, Lisa A. Hom, Sarah B. Clauss, Russell R. Cross, Amy R. Curtis, Rachel D. Steury, Stephanie J. Mitchell, Gerard R. Martin

    We evaluated the effect of an interdisciplinary single-ventricle task force (SVTF) that utilizes a family-driven, telemedicine home monitoring program on clinical outcomes of stage II admissions and its acceptance by parents and cardiologists. Study population was divided into two cohorts, one with Norwood surgery dates before the SVTF (pre-SVTF) and one interventional (post-SVTF). Post-SVTF data also included surveys of parents and cardiologists on the efficacy of the SVTF. Comparative and multivariate statistical testing was performed. Compared to the pre-SVTF group, the post-SVTF group had lower complications after stage II (18.4 vs. 34.1 %, p = 0.02), higher weight-for-age z scores at stage II (−1.5 ± 0.97 vs. −1.58 ± 1.34, p = 0.02) and were less likely to have a stage II weight-for-age z score below −2 (26.5 vs. 31.7 %, p = 0.03). A multivariate regression analysis showed providing a written red-flag action plan to parents at discharge was independently associated with higher weight at stage II (β = 0.42, p = 0.04) and higher weight-for-age z score (β = 0.48, p = 0.02). Parents’ satisfaction with SVTF (α = 0.97) was 4.34 ± 0.62; (95 % CI 4.01–4.67) and cardiologists’ acceptance (α = 0.93) was 4.1 ± 0.7 (95 % CI 3.79–4.42). Development of SVTF was associated with a reduction in complications post-stage II and improved weight status at stage II. A written red-flag action plan provided to parents at the time of Norwood discharge was associated with higher weight status at stage II. Parents and cardiologists expressed satisfaction with the utility of SVTF and encouraged expansion to cover all children with congenital heart disease.